GAT107

CAS No. 1476807-74-5

GAT107( —— )

Catalog No. M34264 CAS No. 1476807-74-5

GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 366 In Stock
10MG 521 In Stock
25MG 781 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GAT107
  • Note
    Research use only, not for human use.
  • Brief Description
    GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.
  • Description
    GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1476807-74-5
  • Formula Weight
    405.31
  • Molecular Formula
    C18H17BrN2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(N)(=O)(=O)C=1C=C2[C@@]3([C@]([C@H](NC2=CC1)C4=CC=C(Br)C=C4)(CC=C3)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • tiquizium

    Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.

  • CP-810123

    CP-810123 is a new alpha 7 nAChR agonist for the treatment of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease.

  • Tazomeline

    Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.